Obesity Trial, Recruiting NCT05237440 Sponsor: University Hospital, Limoges Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05237440
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older
  • Women with a Body Mass Index (BMI) of 30 or above (this is the medical measure used to classify obesity)

Who may not be able to join:

  • People who have previously had weight-loss (bariatric) surgery
  • People who are currently pregnant or breastfeeding
  • People with serious liver problems (hepatocellular insufficiency)
  • People with severe heart failure, or mild to moderate sudden heart failure
  • People with a psychological/mental health condition that has not been stable for at least one year
  • People with alcohol or drug dependence who have not been free of it for at least one year
  • People currently receiving treatment for cancer
  • People with an active infection, or a history of autoimmune disease (except autoimmune thyroid disease), inflammatory disease, or a degenerative brain or nerve condition
  • People who have a growth on an adrenal gland, or any known or suspected problem with the adrenal glands or related hormone system
  • People whose hormone test results suggest they may have too much cortisol (a stress hormone) in their body, based on a specific overnight test result (confirm with trial site)
  • People currently taking antidepressants, antipsychotic medications, or benzodiazepines (a type of medication used for anxiety or sleep)
  • People who have used steroid-based medications (such as cortisone, either by tablet, injection, or other forms) within the last 6 months
  • People currently using anti-inflammatory medications or antibiotics
  • People who work shift work (rotating or non-standard work hours)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 555049818

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Limoges
Registry
ClinicalTrials.gov
Start date
13 April 2022
Est. completion
13 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Measurement of salivary cortisol awakening response (CAR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov